Table 1: Demographic, intraoperative, and postoperative details of patients undergoing laparoscopic liver surgery.

PatientAgeSex ProcedureHistologyOperation timeBlood loss Resection marginLength of Complications
(M/F)(minutes)(mL)(mm)stay (days)

163MRHHCRM240150014Nil
260MWES3HMG2400CE2Nil
351FWES5LCA1200CE3Nil
468FS5/6RCRM2400CE5Nil
574FS4RCRM1800223Nil
669MS6RCRM105053Nil
774MS5R+RIHCRM1800CE7Nil
843FS2RFNH1200CE3Nil
975MS3RCRM2400103Nil
1082MLLBCRM180500CE4Nil
1177MMAS4/8HCC1500CE6Nil
1245FWES6HMG1800456Nil
1364MLLBCRM2400104Nil
1473MS6RCRM24060046Nil
1573MWES6, MAS5HMG900CE4Nil
1670MMAS4aHCC900N/A7Nil
1769MS5RCRM210500CE10Nil
1857FWES5HMG1200CE2Convert to open due to CUSA failure
1936FLLBFNH1200CE3Nil
2034FLLB,MAS4FNH1200CE3Nil
2155MMAS7HMG900N/A2Nil
2258FWES3 SOCLC900CE2Nil
2338MEL: (Planned RHH aborted)CRM Peritoneal deposits900N/A2Nil
2451MWES2/3HMG1200CE3Nil
2547FWE2/3Angiomyo-leiyoma600CE2Nil
2652FWES3Mucinous cystaden-oma600CE1Nil
2762FLDBDC, SOCBiliary cystaden-oma400N/A2Nil
2841FLDLCLC400N/A2Nil
2973FLDLCLC600N/A1Nil
3057FLDBDC, SOCBDC600N/A2Nil
3156FLDLC, SOCLC600N/A1Nil
3284MS5RCRM6010CE1Nil
3342FLDPCLLCPCL300N/A3Nil
3479MLDPCLLCPCL600N/A3Nil
3571FMAS4HCC400N/A2Nil
3632FWES5/6FNH1200303Nil
3743FMAS4Parathyro-ID carcinoma metastasis600N/A1Nil
3851FWES6HMG1200203Nil
3972FS4/S6RCRM200043Nil
4034FMAFNH1300N/A2Nil